Previous 10 | Next 10 |
home / stock / cnsp / cnsp articles
CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) experienced significant movement in its share price Wednesday afternoon. Here's a look at what happene...
Shares of Ovid Therapeutics Inc (NASDAQ:OVID) dipped 65.7% to $1.1285 after Takeda’s Skyline study in Dravet syndrome missed its primary endp...
Shares of AMMO, Inc. (NASDAQ:POWW) fell sharply during Friday's session following fourth-quarter results. AMMO reported a fourth-quarter profi...
Shares of Science Applications International Corporation (NASDAQ:SAIC) declined 11% to $119.91 following first-quarter results. SAIC reported a 9% ...
U.S. stocks traded mostly lower midway through trading, with the Dow Jones falling more than 200 points on Monday. The Dow traded down 0.57% to 38,...
CNS Pharmaceuticals, Inc (NASDAQ:CNSP) shares are trading lower by 33.4% to $0.14 during Monday’s session after the company announced a 1-for...
U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 150 points on Monday. The Dow traded down 0.07% to 38,657.7...
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, whic...
Shares of United Parcel Service, Inc. (NYSE: UPS) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth...
News, Short Squeeze, Breakout and More Instantly...
CNS Pharmaceuticals Inc. Company Name:
CNSP Stock Symbol:
NYSE Market:
CNS Pharmaceuticals Inc. Website:
New research suggests that cancer may have been plaguing individuals even thousands of years ago. Researchers at the University of Cambridge’s Duckworth Laboratory Collection studied skulls obtained from Ancient Egypt, observing lesions which they believe may have been left by malignant t...
CNS Pharmaceuticals (NASDAQ: CNSP) , a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be featured in tomorrow’s Virtual Investor Closing Bell Series. According to the announcemen...
Live video webcast with Chief Executive Officer, John Climaco, on Wednesday, June 17 th at 4:00 PM ET HOUSTON, TX / ACCESSWIRE / July 16, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatm...